Merck, Inc.
🇵🇭Philippines
A Clinical Study to Assess the Effect of Enlicitide on How the Body Processes Digoxin in Healthy Adult Participants (MK-0616-031)
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 24
- Registration Number
- NCT06597760
- Locations
- 🇺🇸
Celerion ( Site 0001), Lincoln, Nebraska, United States
Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants (MK-3543-020)
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 16
- Registration Number
- NCT06596668
- Locations
- 🇺🇸
Celerion, Inc. ( Site 0001), Tempe, Arizona, United States
A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003)
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 12
- Registration Number
- NCT06586606
- Locations
- 🇺🇸
QPS-MRA, LLC ( Site 0001), South Miami, Florida, United States
A Study of MK-0616 in Healthy Adult Participants (MK-0616-009)
- First Posted Date
- 2024-09-12
- Last Posted Date
- 2024-09-12
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 24
- Registration Number
- NCT06592339
- Locations
- 🇺🇸
QPS-MRA, LLC-Early Phase, South Miami, Florida, United States
A Study to Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007)
- First Posted Date
- 2024-09-06
- Last Posted Date
- 2024-09-09
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 40
- Registration Number
- NCT06586671
- Locations
- 🇺🇸
QPS-MRA, LLC-Early Phase (Site 0002), South Miami, Florida, United States
A Study of MK-2060 in Healthy Participants (MK-2060-016)
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 64
- Registration Number
- NCT06582602
- Locations
- 🇺🇸
Advanced Pharma CR, LLC ( Site 0002), Miami, Florida, United States
🇺🇸Alliance for Multispecialty Research, LLC ( Site 0001), Knoxville, Tennessee, United States
A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 12
- Registration Number
- NCT06580587
Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010)
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 60
- Registration Number
- NCT06575595
- Locations
- 🇺🇸
QPS Missouri ( Site 0003), Springfield, Missouri, United States
A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030)
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 40
- Registration Number
- NCT06575959
- Locations
- 🇺🇸
Orlando Clinical Research Center ( Site 0002), Orlando, Florida, United States
🇺🇸The Texas Liver Institute ( Site 0001), San Antonio, Texas, United States
A Study of MK-1084 With Midazolam and Digoxin in Healthy Participants (MK-1084-009)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 28
- Registration Number
- NCT06575933
- Locations
- 🇺🇸
Celerion ( Site 0001), Tempe, Arizona, United States
© Copyright 2024. All Rights Reserved by MedPath